Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Feb;150(2):455–459.

Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumors.

R R Tremblay 1, D Deperthes 1, B Têtu 1, J Y Dubé 1
PMCID: PMC1858270  PMID: 9033261

Abstract

The development of monoclonal antibodies directed against prostatic kallikrein hK2 prompted us to evaluate its content, along with that of hK3 (prostate-specific antigen), in human prostate carcinoma. Seventy tumors categorized according to the M.D. Anderson Hospital classification (grade I to IV) were analyzed by immunohistochemistry. The staining intensity or the kallikrein content of benign prostatic hyperplasia glandular tissue (used as control) and of grade I tumors appeared similar. In grade II to IV tumors, histochemical data revealed highly variable hK2 or hK3 content in approximately 25% of tumors. Such patterns are consistent with a current observation related to heterogeneity of prostate tumors. In addition, a few tumors did not express hK3 (n = 3), hK2 (n = 3), or both (n = 3), indicating that some growth patterns of prostatic neoplasia are associated with a lack of secretion or storage of hK3 or hK2 for immunodetection. This statement also appears relevant to metastases. It was interesting to note that 4% of hK3-negative tumors had detectable hK2. Because of the importance of hK3 as a serum marker of prostate disorder, this study addresses for the first time the question of the relative importance of both hK3 and hK2 in the immunohistochemical diagnosis of prostatic tumors. We conclude that hK2 may add new information to prostate cancer diagnosis and characterization.

Full text

PDF
455

Images in this article

457Figure 1
on p.457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrahamsson P. A., Lilja H., Falkmer S., Wadström L. B. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate. 1988;12(1):39–46. doi: 10.1002/pros.2990120106. [DOI] [PubMed] [Google Scholar]
  2. Brawn P. N., Ayala A. G., Von Eschenbach A. C., Hussey D. H., Johnson D. E. Histologic grading study of prostate adenocarcinoma: the development of a new system and comparison with other methods--a preliminary study. Cancer. 1982 Feb 1;49(3):525–532. doi: 10.1002/1097-0142(19820201)49:3<525::aid-cncr2820490321>3.0.co;2-m. [DOI] [PubMed] [Google Scholar]
  3. Chapdelaine P., Paradis G., Tremblay R. R., Dubé J. Y. High level of expression in the prostate of a human glandular kallikrein mRNA related to prostate-specific antigen. FEBS Lett. 1988 Aug 15;236(1):205–208. doi: 10.1016/0014-5793(88)80315-6. [DOI] [PubMed] [Google Scholar]
  4. Deperthes D., Chapdelaine P., Tremblay R. R., Brunet C., Berton J., Hébert J., Lazure C., Dubé J. Y. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma. Biochim Biophys Acta. 1995 Dec 14;1245(3):311–316. doi: 10.1016/0304-4165(95)00118-2. [DOI] [PubMed] [Google Scholar]
  5. Dubé J. Y., Pelletier G., Gagnon P., Tremblay R. R. Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases. J Urol. 1987 Oct;138(4):883–887. doi: 10.1016/s0022-5347(17)43408-2. [DOI] [PubMed] [Google Scholar]
  6. Gagnon S., Têtu B., Dubé J. Y., Tremblay R. R. Expression of Zn-alpha 2-glycoprotein and PSP-94 in prostatic adenocarcinoma. An immunohistochemical study of 88 cases. Am J Pathol. 1990 May;136(5):1147–1152. [PMC free article] [PubMed] [Google Scholar]
  7. Henttu P., Lukkarinen O., Vihko P. Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate. Int J Cancer. 1990 Apr 15;45(4):654–660. doi: 10.1002/ijc.2910450414. [DOI] [PubMed] [Google Scholar]
  8. Jöbsis A. C., De Vries G. P., Meijer A. E., Ploem J. S. The immunohistochemical detection of prostatic acid phosphatase: its possibilities and limitations in tumour histochemistry. Histochem J. 1981 Nov;13(6):961–973. doi: 10.1007/BF01002636. [DOI] [PubMed] [Google Scholar]
  9. Mathieu M. C., Caillaud J. M. Carcinomes prostatiques: etude en immunoperoxydase avec des antisérums dirigés contre la phosphatase acide prostatique (PAP) et contre l'antigène spécifique de la prostate (PSA). Bull Cancer. 1985;72(5):405–413. [PubMed] [Google Scholar]
  10. McCormack R. T., Rittenhouse H. G., Finlay J. A., Sokoloff R. L., Wang T. J., Wolfert R. L., Lilja H., Oesterling J. E. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urology. 1995 May;45(5):729–744. doi: 10.1016/s0090-4295(99)80076-4. [DOI] [PubMed] [Google Scholar]
  11. Nadji M., Tabei S. Z., Castro A., Chu T. M., Murphy G. P., Wang M. C., Morales A. R. Prostatic-specific antigen: an immunohistologic marker for prostatic neoplasms. Cancer. 1981 Sep 1;48(5):1229–1232. doi: 10.1002/1097-0142(19810901)48:5<1229::aid-cncr2820480529>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  12. Papsidero L. D., Wang M. C., Valenzuela L. A., Murphy G. P., Chu T. M. A prostate antigen in sera of prostatic cancer patients. Cancer Res. 1980 Jul;40(7):2428–2432. [PubMed] [Google Scholar]
  13. Riegman P. H., Vlietstra R. J., van der Korput H. A., Romijn J. C., Trapman J. Identification and androgen-regulated expression of two major human glandular kallikrein-1 (hGK-1) mRNA species. Mol Cell Endocrinol. 1991 Apr;76(1-3):181–190. doi: 10.1016/0303-7207(91)90272-t. [DOI] [PubMed] [Google Scholar]
  14. Tremblay R. R., Deperthes D., Mailloux J., Lemay M., Dubé J. Y. Kallikreins expression in a mature cystic ovarian teratoma. J Clin Lab Anal. 1996;10(4):229–231. doi: 10.1002/(SICI)1098-2825(1996)10:4<229::AID-JCLA9>3.0.CO;2-4. [DOI] [PubMed] [Google Scholar]
  15. Young C. Y., Andrews P. E., Montgomery B. T., Tindall D. J. Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry. 1992 Jan 28;31(3):818–824. doi: 10.1021/bi00118a026. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES